MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin | Zendy

Xianjun Sun | Zendy; Liu Bingyan | Zendy; Shuo Yan | Zendy; Tinghui Jiang | Zendy; Huiqin Cheng | Zendy; Haosheng Jiang | Zendy; Yan Cao | Zendy; Aiwu Mao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin

Author(s) -

Xianjun Sun,

Liu Bingyan,

Shuo Yan,

Tinghui Jiang,

Huiqin Cheng,

Haosheng Jiang,

Yan Cao,

Aiwu Mao

Publication year - 2015

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000430389

Subject(s) - pancreatic cancer , carcinogenesis , cancer research , microrna , ectopic expression , oncogene , tristetraprolin , metastasis , biology , cancer , cell growth , in vivo , viability assay , cell , cell culture , messenger rna , cell cycle , untranslated region , genetics , gene

The microRNA (miR) 29 family has been studied extensively for its involvement in several diseases, and aberrant expression of its members is associated with tumorigenesis and cancer progression. Here, we examined the role of miR-29a in pancreatic cancer and the involvement of tristetraprolin (TTP).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research